Uniqure NV UQ1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:17 AM CEST
4.18quote price arrow up+0.02 (+0.53%)
52 week range
3.90 - 20.05
Loading...
  • Open4.18
  • Day High4.18
  • Day Low4.18
  • Prev Close4.26
  • 52 Week High20.05
  • 52 Week High Date05/12/23
  • 52 Week Low3.90
  • 52 Week Low Date04/30/24

Key Stats

  • Market Cap224.25M
  • Shares Out47.83M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-30.02

KEY STATS

  • Open4.18
  • Day High4.18
  • Day Low4.18
  • Prev Close4.26
  • 52 Week High20.05
  • 52 Week High Date05/12/23
  • 52 Week Low3.90
  • 52 Week Low Date04/30/24
  • Market Cap224.25M
  • Shares Out47.83M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-30.02

RATIOS/PROFITABILITY

  • EPS (TTM)-5.86
  • P/E (TTM)-0.71
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Uniqure NV

 

Profile

MORE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing...
David Meek
Non-Executive Independent Chairman of the Board
Matthew Kapusta CPA
Chief Executive Officer, Executive Director
Pierre Caloz
Chief Operations Officer
Christian Klemt CPA
Chief Financial Officer
Address
Paasheuvelweg 25a
Amsterdam
1105 BP
Netherlands